Everand Logo

Welcome to Everand!

  • STAT

    STAT+: Pharmalittle: We’re reading about a Lilly obesity-drug ad, a $35 cap on inhalers, and more

    Ahead of the Oscars and amid shortages, Lilly is running a new ad campaign urging consumers against vanity use of weight-loss drugs.
    by Ed Silverman Mar 07, 2024 1 minute
    Source: Alex Hogan/STAT

    Rise and shine, everyone, another busy day is on the way. Moreover, this is shaping up to be a sunny one, as well. This is especially welcome news after a few rainy days that left

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Amylyx Pulling Its ALS Drug, GLP-1 Drugs For Parkinson’s, And More
    Amylyx Pharmaceuticals will take its ALS drug Relyvrio off the market in the U.S. and Canada, ending a multi-year saga for patients with the rare neurodegenerative disease.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Lilly Buying A Plant, A Pfizer Antibiotic, And More
    Eli Lilly agreed to acquire a manufacturing facility in Wisconsin from Nexus Pharmaceuticals to produce injectable medicines amid shortages of Mounjaro and Zepbound.
    STAT1 min read
    USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
    With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.

    Related Books & Audiobooks